e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Tuberculosis control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Social determinants of non-successful treatment outcome in culture confirmed pulmonary TB patients in Poland
M. Korzeniewska-Kosela, I. Szczuka, I. Siemion- Szczesniak, J. Kus (Warszawa, Poland)
Source:
Annual Congress 2007 - Tuberculosis control
Session:
Tuberculosis control
Session type:
Electronic Poster Discussion
Number:
4359
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Korzeniewska-Kosela, I. Szczuka, I. Siemion- Szczesniak, J. Kus (Warszawa, Poland). Social determinants of non-successful treatment outcome in culture confirmed pulmonary TB patients in Poland. Eur Respir J 2007; 30: Suppl. 51, 4359
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The reasons of unfavorable outcomes of treatment in pulmonary tuberculosis patients in Kyrgyzstan
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
Impact of social of social risk factor on treatment outcome in patients with culture positive pulmonary tuberculosis (CPPTB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Medical and social criteria of effectiveness of lung resections in pulmonary tuberculosis (TB)
Source: Eur Respir J 2007; 30: Suppl. 51, 199s
Year: 2007
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Significance of low cost pulmonary rehabilitation programme in post-pulmonary tubercular sequelae in patients of low socio-economic marginalized communities in India:Microbiological cure is the beginning and not the end of their illness.
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004
Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001
Analysis of the pulmonary tuberculosis patients social status
Source: Eur Respir J 2004; 24: Suppl. 48, 191s
Year: 2004
On the efficiency of the long-term hospitalization treatment of patients with social problems with severe pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 369s
Year: 2002
Improvement of treatment adherence and success in homeless patients with tuberculosis in Iasi, Romania
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Trend of delay treatment of patient and healthcare system in diagnosis and management of pulmonary tuberculosis in Iran
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept